SEC 13F Intelligence

Fny Investment Advisers, LLC / ALXN

Fny Investment Advisers, LLC’s Alexion Pharmaceuticals Inc Position

Does Fny Investment Advisers, LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 48.4K shares worth $9M in Q2 2021; the fund’s latest 13F (Q2 2026) no longer reports it.

Position Value
$9M
Q2 2021
Shares
48.4K
% of Portfolio
+3.55%
Quarters Held
6
position exited

Position History ALXN

Reported value by quarter
Q2 ’19: $13,000Q2 ’19Q1 ’20: $322,000Q1 ’20Q2 ’20: $403,000Q2 ’20Q3 ’20: $114,000Q3 ’20Q1 ’21: $3MQ1 ’21Q2 ’21: $9MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202148.4K$9M+3.55%
Q1 202117.8K$3M+1.01%
Q3 20201.0K$114,000+0.05%
Q2 20203.6K$403,000+0.23%
Q1 20203.6K$322,000+0.24%
Q2 2019100$13,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fny Investment Advisers, LLC’s full portfolio or all institutional holders of ALXN.